| Article ID | Journal | Published Year | Pages | File Type |
|---|---|---|---|---|
| 9402344 | Journal of Surgical Research | 2005 | 5 Pages |
Abstract
Treatment of pancreatic cancer with the common dietary polyphosphorylated carbohydrate IP6 significantly decreased cellular growth and increased apoptosis. Our findings suggest that IP6 has the potential to become an effective adjunct for pancreatic cancer treatment. Further in vivo and human studies are needed to evaluate safety and clinical utility of this agent in patients with pancreatic cancer.
Related Topics
Health Sciences
Medicine and Dentistry
Surgery
Authors
Ponnandai M.D., Dale R. M.S., Barbara J. B.S., Cynthia Ph.D., Linda Ph.D., David W. (F.A.C.S.),